Katherine Bach Kalin
Director · SELLAS Life Sciences Group, Inc.
IndividualBuying only
- 2025
- Nov 21, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Katherine Bach Kalin. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nostrand Robert L. van - $15K in SLS purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Katherine Bach Kalin?
Katherine Bach Kalin is a corporate insider, tracked as Director of SELLAS Life Sciences Group, Inc. (SLS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Katherine Bach Kalin last file a Form 4?
The only primary Form 4 on record is dated 21 November 2025.
Has Katherine Bach Kalin been buying or selling stock?
Recorded transactions: 1 open-market purchase ($101K) and 0 open-market sales across all tracked filings.
